KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Gilead Sciences (GILD) Inventory Average (2016 - 2025)

Gilead Sciences' Inventory Average history spans 17 years, with the latest figure at $1.8 billion for Q4 2025.

  • For Q4 2025, Inventory Average fell 0.56% year-over-year to $1.8 billion; the TTM value through Dec 2025 reached $1.8 billion, down 0.56%, while the annual FY2025 figure was $1.7 billion, 0.37% changed from the prior year.
  • Inventory Average reached $1.8 billion in Q4 2025 per GILD's latest filing, down from $1.8 billion in the prior quarter.
  • In the past five years, Inventory Average ranged from a high of $1.9 billion in Q3 2024 to a low of $1.5 billion in Q3 2022.
  • Average Inventory Average over 5 years is $1.7 billion, with a median of $1.7 billion recorded in 2021.
  • Peak YoY movement for Inventory Average: soared 81.45% in 2021, then decreased 16.19% in 2022.
  • A 5-year view of Inventory Average shows it stood at $1.6 billion in 2021, then decreased by 9.84% to $1.5 billion in 2022, then grew by 16.16% to $1.7 billion in 2023, then rose by 3.74% to $1.8 billion in 2024, then decreased by 0.56% to $1.8 billion in 2025.
  • Per Business Quant, the three most recent readings for GILD's Inventory Average are $1.8 billion (Q4 2025), $1.8 billion (Q3 2025), and $1.8 billion (Q2 2025).